Cognia Licenses the Cognia Molecular Information Management System to BioSeek, Inc. and Research Groups at Harvard Medical School, Yale Medical School, and SUNY Binghamton
Cognia Corporation, a developer of information products and services that facilitate the integration, management, and utilization of biological and chemical information, announced today that BioSeek, Inc. and research groups at Harvard Medical School, Yale Medical School, and SUNY Binghamton have licensed the Cognia Molecular(TM) information management system.
Research organizations are faced with the daunting task of integrating and managing enormous amounts of publicly available and internally generated information. This information exists in numerous disparate locations, utilizes a wide array of formats, nomenclature and identifiers and is erratically accessible. Researchers are finding it increasingly difficult to find and manage this information — let alone use it effectively. Cognia Molecular gives bench scientists and informaticians an easy-to-use tool to create an integrated centralized knowledge base.
BioSeek will leverage Cognia Molecular’s user friendly curation clients, parsed datasets, powerful automated batch-loading tools, well documented API, links to over thirty five external databases, and simple linking tools to effectively centralize their disparate proprietary and external information. Because of Cognia Molecular’s highly organized relational database architecture that utilizes controlled vocabularies and standard nomenclatures, the integrated information is amenable for analyses with tools such as Cognia Molecular’s integrated complex querying engine and network builder.
BioSeek’s Director of Informatics, Vangelis Hytopoulos, Ph.D., noted, “Cognia Molecular allows our scientists to effectively inspect and visualize our complex systems biology data, and perform integrated searches and comparisons with our extensive internal datasets of gene and drug functions. Overall, Cognia Molecular enhances our ability to explore the complex interactions between different players involved in human disease and provides us with a centralized repository of corporate knowledge and a flexible platform for interactive scientific collaboration.”
The research groups at Harvard Medical School, Yale Medical School and SUNY Binghamton will utilize the system to manage the public and proprietary information that they process on a daily basis. They will also be utilizing the system to share information with their numerous collaborators.
The core product, Cognia Molecular, can be augmented with Cognia’s value-added content products and services, as well as many datasets and systems its customers may already be using. Licenses for Cognia Molecular and related services can be tailored to meet the specific requirements of most organizations. Please contact Cognia’s sales team at productinfo@cognia.com or 212-331-7842 for additional information.
About Cognia
Cognia Corporation is a developer of information products and services that facilitate the integration, management, and utilization of biological and chemical information. Cognia’s information solutions enable pharmaceutical and biotechnology companies to cost-effectively discover and develop new drugs by accelerating research processes. The Cognia Molecular (TM) information management system supports drug discovery efforts in a wide range of disease areas and cellular processes. The development of Cognia Molecular is the result of managing customer relationships with more than one hundred Pharmaceutical, Biotechnology and Research Centers such as Merck & Co., GlaxoSmithKline, Aventis, Schering-Plough Research Institute and learning first-hand about their needs. Cognia distributes life sciences and chemical databases from John Wiley & Sons and are the exclusive North American distributors of the TRANSFAC(R) and TRANSPATH(R) Professional gene regulation databases by BIOBASE GmbH.
